James A. Geraghty

James Geraghty joined Genzyme in 1992. He is responsible for managing the cardiovascular business unit, including current programs as well as product acquisition and partnering transactions. He led Genzyme’s acquisition of SangStat Medical Corporation in 2003 and has also served as president of Genzyme Europe. Prior to joining Genzyme, Mr. Geraghty was vice president of marketing and strategic planning for Baxter/Caremark International. He has also worked as a consultant on international health care strategy at Bain and Company. Mr. Geraghty has a J.D. from Yale Law School, an M.S. from the University of Pennsylvania and a B.A. from Georgetown University.